Who
Yizhe Wang
Operating Partner
Company insider
Files Form 4 as: Operating Partner, Zai Lab; Chief Executive Officer, LianBio.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 20 Jan 2023
- Last trade
- 11 May 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 May 2026filed 8 Jun 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code A | —136,819 at $0.00 | filing |
| 11 May 2026filed 8 Jun 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code A | —59,288 at $0.00 | filing |
| 11 May 2026filed 8 Jun 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code A | —136,819 at $0.00 | filing |
| 11 May 2026filed 8 Jun 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code A | —59,288 at $0.00 | filing |
| 29 Mar 2023filed 31 Mar 2023 | LianBio | SEC FORM 4 Code A | —907,498 at $0.00 | filing |
| 20 Jan 2023filed 24 Jan 2023 | LianBiooption or derivative | SEC FORM 4 Code A | —1,292,324 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.